Eur Rev Med Pharmacol Sci 2018; 22 (18): 5767-5768
DOI: 10.26355/eurrev_201809_15898

Comment on: Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway

M.C. Fascione, A. Amelia, P.C. Pafundi

Department of Medical Surgical, Neurological, Metabolic and Aging Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy. piaclara.pafundi@unicampania.it

Free PDF Download

To cite this article

M.C. Fascione, A. Amelia, P.C. Pafundi
Comment on: Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 18
Pages: 5767-5768
DOI: 10.26355/eurrev_201809_15898

Keywords Related articles:

  1. Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway
  2. Omega-3 polyunsaturated fatty acids alleviate adenine-induced chronic renal failure via regulating ROS production and TGF-β/SMAD pathway
  3. LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway
  4. MicroRNA-495 inhibits the progression of non-small-cell lung cancer by targeting TCF4 and inactivating Wnt/β-catenin pathway
  5. A randomized clinical trial with two omega 3 fatty acid enhanced oral suplements in head and neck cancer ambulatory patients